These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 15381068)
1. Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation. Hirakata M; Tozawa R; Imura Y; Sugiyama Y Biochem Biophys Res Commun; 2004 Oct; 323(3):782-8. PubMed ID: 15381068 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900 [TBL] [Abstract][Full Text] [Related]
3. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia. Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444 [TBL] [Abstract][Full Text] [Related]
4. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways. Mei CL; He P; Cheng B; Liu W; Wang YF; Wan JJ Cell Biol Int; 2009 Mar; 33(3):301-8. PubMed ID: 19114110 [TBL] [Abstract][Full Text] [Related]
7. Estrogen prevents cholesteryl ester accumulation in macrophages induced by the HIV protease inhibitor ritonavir. Wilson ME; Sengoku T; Allred KF J Cell Biochem; 2008 Apr; 103(5):1598-606. PubMed ID: 17879945 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. Dong W; Wang X; Bi S; Pan Z; Liu S; Yu H; Lu H; Lin X; Wang X; Ma T; Zhang W Int J Mol Med; 2014 May; 33(5):1161-8. PubMed ID: 24584901 [TBL] [Abstract][Full Text] [Related]
9. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Cao Z; Ye P; Long C; Chen K; Li X; Wang H Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004. Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329 [TBL] [Abstract][Full Text] [Related]
11. Effects of lycopene on the induction of foam cell formation by modified LDL. Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344 [TBL] [Abstract][Full Text] [Related]
12. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention. Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887 [TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS; Chen WC; Bai X; Wang YD J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820 [TBL] [Abstract][Full Text] [Related]
14. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
16. [PPARγ signal transduction pathway in the foam cell formation induced by visfatin]. Kang J; Cheng B; Jiang L Sheng Li Xue Bao; 2010 Oct; 62(5):427-32. PubMed ID: 20945045 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of grape seed procyanidins on foam cell formation in vitro. Terra X; Fernández-Larrea J; Pujadas G; Ardèvol A; Bladé C; Salvadó J; Arola L; Blay M J Agric Food Chem; 2009 Mar; 57(6):2588-94. PubMed ID: 19292475 [TBL] [Abstract][Full Text] [Related]
18. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice. Thorp E; Kuriakose G; Shah YM; Gonzalez FJ; Tabas I Circulation; 2007 Nov; 116(19):2182-90. PubMed ID: 17967777 [TBL] [Abstract][Full Text] [Related]
19. Ghrelin inhibits foam cell formation via simultaneously down-regulating the expression of acyl-coenzyme A:cholesterol acyltransferase 1 and up-regulating adenosine triphosphate-binding cassette transporter A1. Cheng B; Wan J; Wang Y; Mei C; Liu W; Ke L; He P Cardiovasc Pathol; 2010; 19(5):e159-66. PubMed ID: 19747856 [TBL] [Abstract][Full Text] [Related]
20. PPARα/γ signaling pathways are involved in Chlamydia pneumoniae-induced foam cell formation via upregulation of SR-A1 and ACAT1 and downregulation of ABCA1/G1. Wu X; Cheng B; Guo X; Wu Q; Sun S; He P Microb Pathog; 2021 Dec; 161(Pt B):105284. PubMed ID: 34767930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]